Tech Company Financing Transactions

Antegenes Funding Round

Private investors invested in a $2.4 million funding round for Antegenes. This VC investment round was announced on 8/7/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

Raatuse 21
Tartu, 50603
Estonia

Phone

+372 5377 8141

Website

www.antegenes.com

Email Address

[email protected]

Overview

We have developed novel polygenic risk score based genetic tests to estimate the risk of common cancers. The polygenic risk score sums up information over hundreds to thousands of genetic variants in the human genome. Our mission is to enable people to have a better, healthier, and longer life by helping individuals, healthcare professionals, and organizations use genetic information for personal and public health.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peeter Padrik

        

Chief Operating Officer

Berit Kolk

        

Chief Technical Officer

Mikk Puustusmaa

        

VP - Product Management

Siim Sõber

        

Browse more venture capital transactions:

Prev: 8/7/2022: Hive Wealth by Impart Media venture capital transaction
Next: 8/7/2022: Everytable venture capital transaction

Share this article

About Database of VC Transactions

We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary